April 16, 2015 | Sun Pharmaceutical Industries and the Technion Israel Institute of Technology announced that they have entered into a worldwide research and licence agreement. The agreement is aimed at the development of a joint project, based on findings made by Nobel Prize laureate Aaron Ciechanover, that could potentially lead to the development of anti-cancer drugs.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments